Provision of Hydration and Nutrition for the Terminally Ill

Debate between Thomas Docherty and Andrew George

Wednesday 14th September 2011 Commons Chamber

[Andrew George]

Thank you, Mr Speaker.

As I was saying, Benjamin Franklin said:

“In this world nothing can be said to be certain, except death and taxes.”

As the House debates and comes to conclusions on taxes, it is also appropriate for us to consider—and to consider deeply—ethical questions such as the manner and process of death. We should ensure that end-of-life care and the ethical questions surrounding it are carefully considered.

It is my intention to deal not with the legal case surrounding the death of Tony Bland, but with the implications of the Bill on the GMC and on other guidance on the application of the Liverpool care pathway. Like others, I have been confronted by those issues, with the loss of a very close family member in recent months. Such questions inevitably and sadly confront us all.

Medical treatment of the terminally ill should be in the patient’s best interests. We should recognise that a blanket policy—of always providing, or of always not providing, artificial nutrition and hydration—would be ethically indefensible. Therefore, all decisions on medical interventions, which is what we are debating, should be based on sound, clinical judgment.

I agree with my hon. Friend that these matters should be kept under review. It is absolutely appropriate that the current guidance that applies is kept under review, and that the House of Commons and the House of Lords should be involved in debates on it.

The Liverpool care pathway is used in hospitals as a plan of care for patients in the last days and hours of their life. The pathway is recommended as best practice in the end-of-life care strategy. Patients should be involved in decision making wherever possible, and they have a right to refuse treatment in person, or in advance of a loss of capacity. Health care professionals should seek to provide the highest standards of care possible to dying patients. On occasion, that will involve recognising that a patient who is hours, or at most days, away from death, will be harmed rather than helped by the application of artificial nutrition and hydration.

The GMC guidance to doctors on end-of-life decision making states:

“All patients are entitled to food and drink of adequate quantity and quality and to the help they need to eat and drink…You must keep the nutrition and hydration status of your patients under review. You should be satisfied that nutrition and hydration are being provided in a way that meets your patients’ needs, and that if necessary patients are being given adequate help to enable them to eat and drink”,

hence the application of the artificial intervention to assist them.

The guidance also states:

“If a patient is expected to die within hours or days, and you consider that the burdens…of providing clinically assisted nutrition or hydration outweigh the benefits they are likely to bring, it will not usually be appropriate to start or continue treatment.”

Similar advice is provided by the National Council for Palliative Care.

The benefits of artificially provided nutrition and hydration include the potential to prolong life and improve general well-being. Artificial nutrition could prolong life in patients with obstructing tumours, such as throat cancers, or those with diseases that prevent them from swallowing, such as motor neurone disease. Artificial hydration could in certain circumstances also relieve thirst.

However, there are also risks. In some circumstances, artificial nutrition and hydration will only prolong the period of suffering, and there could be complications associated with having tubes inserted. Fluids given via drip can exacerbate oedema—swelling—and increase leakage into body spaces that can lead to a more distressing death, for example if fluids get into the lungs.

It is important, therefore, that in debating this issue, which I hope the the House will have time to do—because it needs to be kept under review—we will have an opportunity to consider the risks of continuing to apply artificial nutrition and hydration. That issue has been well covered by the General Medical Council and others in the clinical guidance that needs to apply here. The Liverpool care pathway has been accused of encouraging a tick-box culture that does not consider the whole patient and their needs. We have to ensure that the highest-possible clinical standards are applied when the LCP is administered. Equally, as my hon. Friend said, we have to strike a balance between the patient’s best interests and wishes and the wishes of the family close to the terminally ill patient. She emphasises, in the title of the Bill, that this is a matter of the right to treatment, but it is also a matter to be balanced with the right to ensure that medical interventions are in the best interests of patients. On that basis, I wish to ensure that we strike a balance when we debate the Bill.

Question put and agreed to.

Ordered,

That Dr Thérèse Coffey, Andrea Leadsom, Penny Mordaunt, Harriett Baldwin, Jim Dobbin, Thomas Docherty, Mr Andrew Turner and Dr Julian Lewis present the Bill.

Dr Thérèse Coffey accordingly presented the Bill.

Bill read the First time; to be read a Second time on Friday 25 November, and to be printed (Bill 230).

[Thomas Docherty (Dunfermline and West Fife) (Lab)]

On a point of order, Mr Speaker. This is a genuine question. Will you clarify for Members the rules on speeches during the presentation of a ten-minute rule Bill?